The Covid-19 vaccine of Indian pharmaceutical firm Gennova Biopharmaceuticals, the first homegrown mRNA-based shot, was found to be safe and effective in an early-stage study, the government said.

Government authorities have also approved further studies to test the vaccine’s efficacy in a larger population. Gennova plans to conduct a mid-stage study at about 10 to 15 sites and a late-stage trial at 22 to 27 sites in India.
https://www.news18.com/news/india/covid-19-india-says-homegrown-mrn...